3,424
Views
22
CrossRef citations to date
0
Altmetric
Article

Feasibility of MRI-guided transurethral ultrasound for lesion-targeted ablation of prostate cancer

ORCID Icon, , ORCID Icon, , , , , , , & show all
Pages 295-302 | Received 22 May 2019, Accepted 23 Aug 2019, Published online: 26 Sep 2019

References

  • Hamdy FC, Donovan JL, Lane JA, et al. 10-Year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. N Engl J Med. 2016;375(15):1415–1424.
  • Wilt TJ, Jones KM, Barry MJ, et al. Follow-up of prostatectomy versus observation for early prostate cancer. N Engl J Med. 2017;377(2):132–142.
  • Bill-Axelson A, Holmberg L, Garmo H, et al. Radical prostatectomy or watchful waiting in early prostate cancer. N Engl J Med. 2014;370(10):932–942.
  • Donovan JL, Hamdy FC, Lane JA, et al. Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer. N Engl J Med. 2016;375(15):1425–1437.
  • Valerio M, Cerantola Y, Eggener SE, et al. New and established technology in focal ablation of the prostate: a systematic review. Eur Urol. 2017;71(1):17–34.
  • Ahmed HU, El-Shater Bosaily A, Brown LC, et al. Diagnostic accuracy of Multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet. 2017;389(10071):815–822.
  • Kasivisvanathan V, Rannikko AS, Borghi M, et al. MRI-targeted or standard biopsy for Prostate-cancer diagnosis. N Engl J Med. 2018;378(19):1767–1777.
  • Ishihara Y, Calderon A, Watanabe H, et al. A precise and fast temperature mapping using water proton chemical shift. Magn Reson Med. 1995;34(6):814–823.
  • Chopra R, Tang K, Burtnyk M, et al. Analysis of the spatial and temporal accuracy of heating in the prostate gland using transurethral ultrasound therapy and active MR temperature feedback. Phys Med Biol. 2009;54(9):2615.
  • Böni RA, Sulser T, Jochum W, et al. Laser ablation-induced changes in the prostate: findings at endorectal MR imaging with histologic correlation. Radiology. 1997;202(1):232–236.
  • Rouvière O, Lyonnet D, Raudrant A, et al. MRI appearance of prostate following transrectal HIFU ablation of localized cancer. Eur Urol. 2001;40:265–274.
  • Rosset R, Bratan F, Crouzet S, et al. Can pre- and postoperative magnetic resonance imaging predict recurrence-free survival after whole-gland high-intensity focused ablation for prostate cancer? Eur Radiol. 2017;27(4):1768–1775.
  • Boyes A, Tang K, Yaffe M, et al. Prostate tissue analysis immediately following magnetic resonance imaging guided transurethral ultrasound thermal therapy. J Urol. 2007;178.(3):1080–1085.
  • Sapareto SA, Dewey WC. Thermal dose determination in cancer therapy. Int J Radiat Oncol Biol Phys. 1984;10(6):787–800.
  • Chu KF, Dupuy DE. Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer. 2014;14(3):199–208.
  • Burtnyk M, Hill T, Cadieux-Pitre H, et al. Magnetic resonance image guided transurethral ultrasound prostate ablation: a preclinical safety and feasibility study with 28-day followup. J Urol. 2015;193(5):1669–1675.
  • Siddiqui K, Chopra R, Vedula S, et al. MRI-guided transurethral ultrasound therapy of the prostate gland using Real-time thermal mapping: initial studies. Urology. 2010;76(6):1506–1511.
  • Chin JL, Billia M, Relle J, et al. Magnetic resonance imaging-guided transurethral ultrasound ablation of prostate tissue in patients with localized prostate cancer: a prospective phase 1 clinical trial. Eur Urol. 2016;70(3):447–455.
  • Ramsay E, Mougenot C, Staruch R, et al. Evaluation of focal ablation of magnetic resonance imaging defined prostate cancer using magnetic resonance imaging controlled transurethral ultrasound therapy with prostatectomy as the reference standard. J Urol. 2017;197(1):255–261.
  • Chopra R, Colquhoun A, Burtnyk M, et al. MR imaging-controlled transurethral ultrasound therapy for conformal treatment of prostate tissue: initial feasibility in humans. Radiology. 2012;265(1):303–313.
  • Weinreb JC, Barentsz JO, Choyke PL, et al. PI-RADS prostate imaging – Reporting and data system: 2015, version 2. Eur Urol. 2016;69(1):16–40.
  • Priester A, Natarajan S, Khoshnoodi P, et al. Magnetic resonance imaging underestimation of prostate cancer geometry: use of patient specific molds to correlate images with whole mount pathology. J Urol. 2017;197(2):320–326.
  • Lindner U, Lawrentschuk N, Weersink RA, et al. Focal laser ablation for prostate cancer followed by radical prostatectomy: validation of focal therapy and imaging accuracy. Eur Urol. 2010;57(6):1111–1114.
  • Bomers JGR, Cornel EB, Futterer JJ, et al. MRI-guided focal laser ablation for prostate cancer followed by radical prostatectomy: correlation of treatment effects with imaging. World J Urol. 2017;35(5):703–711.
  • Napoli A, Anzidei M, De Nunzio C, et al. Real-time Magnetic Resonance–guided High-intensity focused ultrasound focal therapy for localised prostate cancer: preliminary experience. Eur. Urol. 2013;63(2):395–398.
  • Eggener S, Penson D, Pavlovich C, et al. LBA-26 Pivotal trial of MRI-guided transurethral ultrasound ablation in men with localized prostate cancer. J. Urol. 2019;20:e1004.